Abstract
HIV-1 evades antibody-mediated neutralization in many cunning ways. The recent structural characterization of a conserved neutralization epitope on the envelope glycoprotein complex (Env) provides clues to the vulnerabilities of the virus. We discuss these observations and explain their relevance for HIV-1 vaccine design.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AIDS Vaccines / immunology*
-
Antibody Specificity / immunology*
-
Drug Design
-
Epitopes / chemistry
-
Epitopes / immunology
-
HIV Envelope Protein gp120* / chemistry
-
HIV Envelope Protein gp120* / immunology
-
HIV Infections / immunology
-
HIV Infections / prevention & control*
-
HIV-1 / immunology*
-
Humans
-
Protein Structure, Tertiary
Substances
-
AIDS Vaccines
-
Epitopes
-
HIV Envelope Protein gp120